Citations (91)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (13)
Yi-Kun Wang, Xiao-Nan Yang, Wei-Qing Liang, Yao Xiao, Qi Zhao, Xue-Rong Xiao, Frank J. Gonzalez & Fei Li. (2019) A metabolomic perspective of pazopanib-induced acute hepatotoxicity in mice. Xenobiotica 49:6, pages 655-670.
Read now
Read now
Poonam Giri, Prashant Delvadia, Laxmikant Gupta, Nirmal Patel, Priyal Trivedi, Krishna Lad, Hiren M. Patel & Nuggehally R. Srinivas. (2018) Consequences of daily corticosteroid dosing with or without pre-treatment with quinidine on the in vivo cytochrome P450 2D (CYP2D) enzyme in rats: effect on O-demethylation activity of dextromethorphan and expression levels of CYP2D1 mRNA. Xenobiotica 48:1, pages 1-10.
Read now
Read now
Yanwen Cheng, Xiaoling Liang, Liying Feng, Duo Liu, Mengnan Qin, Shuang Liu, Gaofeng Liu & Mei Dong. (2017) Effects of phillyrin and forsythoside A on rat cytochrome P450 activities in vivo and in vitro. Xenobiotica 47:4, pages 297-303.
Read now
Read now
Madia Lozupone, Francesco Panza, Eleonora Stella, Maddalena La Montagna, Paola Bisceglia, Giuseppe Miscio, Ilaria Galizia, Antonio Daniele, Lazzaro di Mauro, Antonello Bellomo, Giancarlo Logroscino, Antonio Greco & Davide Seripa. (2017) Pharmacogenetics of neurological and psychiatric diseases at older age: has the time come?. Expert Opinion on Drug Metabolism & Toxicology 13:3, pages 259-277.
Read now
Read now
Francesco Panza, Madia Lozupone, Eleonora Stella, Lucia Lofano, Carolina Gravina, Maria Urbano, Antonio Daniele, Antonello Bellomo, Giancarlo Logroscino, Antonio Greco & Davide Seripa. (2016) Psychiatry meets pharmacogenetics for the treatment of revolving door patients with psychiatric disorders. Expert Review of Neurotherapeutics 16:12, pages 1357-1369.
Read now
Read now
Francesco Panza, Madia Lozupone, Eleonora Stella, Giuseppe Miscio, Maddalena La Montagna, Antonio Daniele, Lazzaro di Mauro, Antonello Bellomo, Giancarlo Logroscino, Antonio Greco & Davide Seripa. (2016) The pharmacogenetic road to avoid adverse drug reactions and therapeutic failures in revolving door patients with psychiatric illnesses: focus on the CYP2D6 isoenzymes. Expert Review of Precision Medicine and Drug Development 1:5, pages 431-442.
Read now
Read now
Kevin A. Ford, Gregory Ryslik, Jasleen Sodhi, Jason Halladay, Dolo Diaz, Donna Dambach & Melisa Masuda. (2015) Computational predictions of the site of metabolism of cytochrome P450 2D6 substrates: comparative analysis, molecular docking, bioactivation and toxicological implications. Drug Metabolism Reviews 47:3, pages 291-319.
Read now
Read now
Jie Cheng, Yueying Zhen, Sharon Miksys, Diren Beyoğlu, Kristopher W. Krausz, Rachel F. Tyndale, Aiming Yu, Jeffrey R. Idle & Frank J. Gonzalez. (2013) Potential role of CYP2D6 in the central nervous system. Xenobiotica 43:11, pages 973-984.
Read now
Read now
Angus N.R. Nedderman, Gordon J. Dear, Stephanie North, R. Scott Obach & David Higton. (2011) From definition to implementation: a cross-industry perspective of past, current and future MIST strategies. Xenobiotica 41:8, pages 605-622.
Read now
Read now
Xi-Ling Jiang, Frank J. Gonzalez & Ai-Ming Yu. (2011) Drug-metabolizing enzyme, transporter, and nuclear receptor genetically modified mouse models. Drug Metabolism Reviews 43:1, pages 27-40.
Read now
Read now
M Filopanti, AG Lania & A Spada. (2010) Pharmacogenetics of D2 dopamine receptor gene in prolactin-secreting pituitary adenomas. Expert Opinion on Drug Metabolism & Toxicology 6:1, pages 43-53.
Read now
Read now
Katsutoshi Yoshizato & Chise Tateno. (2009) In vivo modeling of human liver for pharmacological study using humanized mouse. Expert Opinion on Drug Metabolism & Toxicology 5:11, pages 1435-1446.
Read now
Read now
J.C. Callaway. (2005) Fast and Slow Metabolizers of Hoasca
. Journal of Psychoactive Drugs 37:2, pages 157-161.
Read now
Read now
Articles from other publishers (78)
Iva Spreitzer, Josefin Keife, Tobias Strasser, Predrag Kalaba, Jana Lubec, Winfried Neuhaus, Gert Lubec, Thierry Langer, Judith Wackerlig & Irena Loryan. (2023) Pharmacokinetics of Novel Dopamine Transporter Inhibitor CE-123 and Modafinil with a Focus on Central Nervous System Distribution. International Journal of Molecular Sciences 24:23, pages 16956.
Crossref
Crossref
Mitra Samadi, Laleh Beigi, Fatemeh Yadegari, Alireza Madjid Ansari, Keivan Majidzadeh-A, Maryam Eskordi & Leila Farahmand. (2022) Recognition of functional genetic polymorphism using ESE motif definition: a conservative evolutionary approach to CYP2D6/CYP2C19 gene variants. Genetica 150:5, pages 289-297.
Crossref
Crossref
Johannes T. Reckweg, Malin V. Uthaug, Attila Szabo, Alan K. Davis, Rafael Lancelotta, Natasha L. Mason & Johannes G. Ramaekers. (2022) The clinical pharmacology and potential therapeutic applications of 5‐methoxy‐N,N‐dimethyltryptamine (5‐MeO‐DMT). Journal of Neurochemistry 162:1, pages 128-146.
Crossref
Crossref
Malavika Deodhar, Jacques Turgeon & Veronique Michaud. (2021) Contribution of CYP2D6 Functional Activity to Oxycodone Efficacy in Pain Management: Genetic Polymorphisms, Phenoconversion, and Tissue-Selective Metabolism. Pharmaceutics 13:9, pages 1466.
Crossref
Crossref
Andy C. Dean, Erika L. Nurmi, Angelica M. Morales, Arthur K. Cho, Lauren C. Seaman & Edythe D. London. (2020)
CYP2D6
genotype may moderate measures of brain structure in methamphetamine users
. Addiction Biology 26:3.
Crossref
Crossref
Edgor Cole Tolledo, Sharon Miksys, Frank J. Gonzalez & Rachel F. Tyndale. (2020) Propranolol is a mechanism‐based inhibitor of CYP2D and CYP2D6 in humanized CYP2D6‐transgenic mice: Effects on activity and drug responses. British Journal of Pharmacology 177:3, pages 701-712.
Crossref
Crossref
Mrittika Chattopadhyay, Anindya Roy Chowdhury, Ting Feng, Charles-Antoine Assenmacher, Enrico Radaelli, F. Peter Guengerich & Narayan G. Avadhani. (2019) Mitochondrially targeted cytochrome P450 2D6 is involved in monomethylamine-induced neuronal damage in mouse models. Journal of Biological Chemistry 294:26, pages 10336-10348.
Crossref
Crossref
Jing Li, Feiyue Xing, Feng Chen, Liumin He, Kwok-Fai So, Yingxia Liu & Jia Xiao. (2018) Functional 3D Human Liver Bud Assembled from MSC-Derived Multiple Liver Cell Lineages. Cell Transplantation 28:5, pages 510-521.
Crossref
Crossref
Hermann M. Niemeyer, Patricio de Souza, Conrado Camilo & Javier Echeverría. (2018) Chemical evidence of prehistoric passive tobacco consumption by a human perinate (early Formative Period, South-Central Andes). Journal of Archaeological Science 100, pages 130-138.
Crossref
Crossref
Karl-Dimiter Bissig, Weiguo Han, Mercedes Barzi, Nataliia Kovalchuk, Liang Ding, Xiaoyu Fan, Francis P. Pankowicz, Qing-Yu Zhang & Xinxin Ding. (2018) P450-Humanized and Human Liver Chimeric Mouse Models for Studying Xenobiotic Metabolism and Toxicity. Drug Metabolism and Disposition 46:11, pages 1734-1744.
Crossref
Crossref
Yongfa Su, Zhanfei Chen, Linlin Yan, Fen Lian, Jianhua You, Xiaoqian Wang & Nanhong Tang. (2018) Optimizing combination of liver-enriched transcription factors and nuclear receptors simultaneously favors ammonia and drug metabolism in liver cells. Experimental Cell Research 362:2, pages 504-514.
Crossref
Crossref
Nirmala Mavila, Andrew Trecartin, Ryan Spurrier, Yi Xiao, Xiaogang Hou, David James, Xiaowei Fu, Brian Truong, Clara Wang, Gerald S. Lipshutz, Kasper S. Wang & Tracy C. Grikscheit. (2017) Functional Human and Murine Tissue-Engineered Liver Is Generated from Adult Stem/Progenitor Cells. Stem Cells Translational Medicine 6:1, pages 238-248.
Crossref
Crossref
A. Kenneth MacLeod, Lesley A. McLaughlin, Colin J. Henderson & C. Roland Wolf. (2017) Application of Mice Humanized for CYP2D6 to the Study of Tamoxifen Metabolism and Drug–Drug Interaction with Antidepressants. Drug Metabolism and Disposition 45:1, pages 17-22.
Crossref
Crossref
Xian Pan, Miaoran Ning & Hyunyoung Jeong. (2017) Transcriptional Regulation of CYP2D6 Expression. Drug Metabolism and Disposition 45:1, pages 42-48.
Crossref
Crossref
Curtis P. Snook. 2017. Critical Care Toxicology. Critical Care Toxicology
1587
1607
.
Erin P. Madeen, Christiane V. Löhr, Hannah You, Lisbeth K. Siddens, Sharon K. Krueger, Roderick H. Dashwood, Frank J. Gonzalez, William M. Baird, Emily Ho, Lisa Bramer, Katrina M. Waters & David E. Williams. (2017)
Dibenzo[
def,p
]chrysene transplacental carcinogenesis in wild-type,
Cyp1b1
knockout, and
CYP1B1
humanized mice
. Molecular Carcinogenesis 56:1, pages 163-171.
Crossref
Crossref
M. Farooq, E. J. Kelly & J. D. Unadkat. (2016) CYP2D6 Is Inducible by Endogenous and Exogenous Corticosteroids. Drug Metabolism and Disposition 44:5, pages 750-757.
Crossref
Crossref
Curtis P. Snook. 2016. Critical Care Toxicology. Critical Care Toxicology
1
22
.
Ran-Ran Zhang, Yun-Wen Zheng, Bin Li, Tomonori Tsuchida, Yasuharu Ueno, Yun-Zhong Nie & Hideki Taniguchi. (2015) Human hepatic stem cells transplanted into a fulminant hepatic failure Alb-TRECK/SCID mouse model exhibit liver reconstitution and drug metabolism capabilities. Stem Cell Research & Therapy 6:1.
Crossref
Crossref
Łukasz Gricman, Constantin Vogel & Jürgen Pleiss. (2015) Identification of universal selectivity-determining positions in cytochrome P450 monooxygenases by systematic sequence-based literature mining. Proteins: Structure, Function, and Bioinformatics 83:9, pages 1593-1603.
Crossref
Crossref
Miaoran Ning, Kwi Hye Koh, Xian Pan & Hyunyoung Jeong. (2015) Hepatocyte nuclear factor (HNF) 4α transactivation of cytochrome P450 (Cyp) 2d40 promoter is enhanced during pregnancy in mice. Biochemical Pharmacology 94:1, pages 46-52.
Crossref
Crossref
L. M. Upton, P. M. Brock, T. S. Churcher, A. C. Ghani, P. W. Gething, M. J. Delves, K. A. Sala, D. Leroy, R. E. Sinden & A. M. Blagborough. (2015) Lead Clinical and Preclinical Antimalarial Drugs Can Significantly Reduce Sporozoite Transmission to Vertebrate Populations. Antimicrobial Agents and Chemotherapy 59:1, pages 490-497.
Crossref
Crossref
Kwi Hye Koh, Xian Pan, Wei Zhang, Alan McLachlan, Raul Urrutia & Hyunyoung Jeong. (2014) Krüppel-Like Factor 9 Promotes Hepatic Cytochrome P450 2D6 Expression during Pregnancy in CYP2D6-Humanized Mice. Molecular Pharmacology 86:6, pages 727-735.
Crossref
Crossref
Eva M. Peñas-LLedó & Adrián LLerena. (2014) CYP2D6 variation, behaviour and psychopathology: implications for pharmacogenomics-guided clinical trials. British Journal of Clinical Pharmacology 77:4, pages 673-683.
Crossref
Crossref
Kwi Hye Koh, Xian Pan, Hong-Wu Shen, Samuel L.M. Arnold, Ai-Ming Yu, Frank J. Gonzalez, Nina Isoherranen & Hyunyoung Jeong. (2014) Altered Expression of Small Heterodimer Partner Governs Cytochrome P450 (CYP) 2D6 Induction during Pregnancy in CYP2D6-humanized Mice. Journal of Biological Chemistry 289:6, pages 3105-3113.
Crossref
Crossref
Shuichi Kuno, Fuminori Sakurai, Kahori Shimizu, Naoya Matsumura, Soonih Kim, Hitoshi Watanabe, Katsuhisa Tashiro, Masashi Tachibana, Tsuyoshi Yokoi & Hiroyuki Mizuguchi. (2014) Development of Mice Exhibiting Hepatic Microsomal Activity of Human CYP3A4 Comparable to That in Human Liver Microsomes by Intravenous Administration of an Adenovirus Vector Expressing Human CYP3A4. Drug Metabolism and Pharmacokinetics 29:4, pages 296-304.
Crossref
Crossref
Brandon S Pybus, Sean R Marcsisin, Xiannu Jin, Gregory Deye, Jason C Sousa, Qigui Li, Diana Caridha, Qiang Zeng, Gregory A Reichard, Christian Ockenhouse, Jason Bennett, Larry A Walker, Colin Ohrt & Victor Melendez. (2013) The metabolism of primaquine to its active metabolite is dependent on CYP 2D6. Malaria Journal 12:1.
Crossref
Crossref
Anders Helldén & Parvaz Madadi. (2013) Pregnancy and pharmacogenomics in the context of drug metabolism and response. Pharmacogenomics 14:14, pages 1779-1791.
Crossref
Crossref
Javier Echeverría & Hermann M. Niemeyer. (2013) Nicotine in the hair of mummies from San Pedro de Atacama (Northern Chile). Journal of Archaeological Science 40:10, pages 3561-3568.
Crossref
Crossref
Takanori Takebe, Keisuke Sekine, Masahiro Enomura, Hiroyuki Koike, Masaki Kimura, Takunori Ogaeri, Ran-Ran Zhang, Yasuharu Ueno, Yun-Wen Zheng, Naoto Koike, Shinsuke Aoyama, Yasuhisa Adachi & Hideki Taniguchi. (2013) Vascularized and functional human liver from an iPSC-derived organ bud transplant. Nature 499:7459, pages 481-484.
Crossref
Crossref
Colin J. Henderson, Lesley A. McLaughlin & C. Roland Wolf. (2013)
Evidence That Cytochrome
b
5
and Cytochrome
b
5
Reductase Can Act as Sole Electron Donors to the Hepatic Cytochrome P450 System
. Molecular Pharmacology 83:6, pages 1209-1217.
Crossref
Crossref
Xi-Ling Jiang, Hong-Wu Shen, Donald E. Mager & Ai-Ming Yu. (2013)
Pharmacokinetic Interactions between Monoamine Oxidase A Inhibitor Harmaline and 5-Methoxy-
N,N
-Dimethyltryptamine, and the Impact of CYP2D6 Status
. Drug Metabolism and Disposition 41:5, pages 975-986.
Crossref
Crossref
Silvio Caccia, Luca Pasina & Alessandro Nobili. (2013) How pre-marketing data can be used for predicting the weight of drug interactions in clinical practice. European Journal of Internal Medicine 24:3, pages 217-221.
Crossref
Crossref
Alexander V. LyubimovAndrew Bessire, Kuresh Youdim, Susan Hurst & Caroline A. Lee. 2011. Encyclopedia of Drug Metabolism and Interactions. Encyclopedia of Drug Metabolism and Interactions
1
88
.
Hadine Joffe, Thilo Deckersbach, Nancy U. Lin, Nikos Makris, Todd C. Skaar, Scott L. Rauch, Darin D. Dougherty & Janet E. Hall. (2012) Metabolic Activity in the Insular Cortex and Hypothalamus Predicts Hot Flashes: An FDG-PET Study. The Journal of Clinical Endocrinology & Metabolism 97:9, pages 3207-3215.
Crossref
Crossref
Hua Cai, Jun Jiang, Qi Yang, Qingmei Chen & Yiqun Deng. (2012) Functional Characterization of a First Avian Cytochrome P450 of the CYP2D Subfamily (CYP2D49). PLoS ONE 7:6, pages e38395.
Crossref
Crossref
Kevin L. Salyers & Yang Xu. 2012. ADME‐Enabling Technologies in Drug Design and Development. ADME‐Enabling Technologies in Drug Design and Development
253
276
.
Ai-Ming Yu & Yu-Zhuo Pan. (2012) Noncoding microRNAs: small RNAs play a big role in regulation of ADME?. Acta Pharmaceutica Sinica B 2:2, pages 93-101.
Crossref
Crossref
Akihide Kamiya & Atsushi Miyajima. (2012) Mice with artificial human liver. Hepatology 55:3, pages 974-977.
Crossref
Crossref
Parvaz Madadi & Gideon Koren. 2012. Pharmacogenomics in Clinical Therapeutics. Pharmacogenomics in Clinical Therapeutics
1
14
.
Yong Wang, Hai-Hong Hu, Hao Pang, Xiao-Yang Zhou, Lu-Shan Yu, Lu-Lu Wang, Cang'e Liu, Ke-Nan Guo, Cong Zhao, Qin Liu, Ben-Hua Zeng, Huan Tang, Hai-Tao Shang, Su Zeng & Hong Wei. (2012) Lentiviral Transgenic MicroRNA-Based shRNA Suppressed Mouse Cytochromosome P450 3A (CYP3A) Expression in a Dose-Dependent and Inheritable Manner. PLoS ONE 7:1, pages e30560.
Crossref
Crossref
Nico Scheer, Yury Kapelyukh, Jillian McEwan, Vincent Beuger, Lesley A. Stanley, Anja Rode & C. Roland Wolf. (2012) Modeling Human Cytochrome P450 2D6 Metabolism and Drug-Drug Interaction by a Novel Panel of Knockout and Humanized Mouse Lines. Molecular Pharmacology 81:1, pages 63-72.
Crossref
Crossref
F. Peter Guengerich & Qian Cheng. (2011) Orphans in the Human Cytochrome P450 Superfamily: Approaches to Discovering Functions and Relevance in Pharmacology. Pharmacological Reviews 63:3, pages 684-699.
Crossref
Crossref
J.C. Winter, D.J. Amorosi, Kenner C. Rice, Kejun Cheng & Ai-Ming Yu. (2011) Stimulus control by 5-methoxy-N,N-dimethyltryptamine in wild-type and CYP2D6-humanized mice. Pharmacology Biochemistry and Behavior 99:3, pages 311-315.
Crossref
Crossref
Alice A. ChenDavid K. ThomasLuvena L. OngRobert E. SchwartzTodd R. Golub & Sangeeta N. Bhatia. (2011) Humanized mice with ectopic artificial liver tissues. Proceedings of the National Academy of Sciences 108:29, pages 11842-11847.
Crossref
Crossref
Gaofeng Liu, Yan Liu, Rui Liu, Feng Dong & Zhiren Zhang. (2011)
Effects of
Flos carthami
on CYP2D6 and on the Pharmacokinetics of Metoprolol in Rats
. Evidence-Based Complementary and Alternative Medicine 2011, pages 1-7.
Crossref
Crossref
Kazuaki Chayama, C Nelson Hayes, Nobuhiko Hiraga, Hiromi Abe, Masataka Tsuge & Michio Imamura. (2011) Animal model for study of human hepatitis viruses. Journal of Gastroenterology and Hepatology 26:1, pages 13-18.
Crossref
Crossref
T. Wassenberg, M.A.A.P. Willemsen, P.B.H. Geurtz, M. Lammens, K. Verrijp, M. Wilmer, W.T. Lee, R.A. Wevers & M.M. Verbeek. (2010) Urinary dopamine in aromatic L-amino acid decarboxylase deficiency: The unsolved paradox. Molecular Genetics and Metabolism 101:4, pages 349-356.
Crossref
Crossref
Sean C Gay, Arthur G Roberts & James R Halpert. (2010) Structural features of cytochromes P450 and ligands that affect drug metabolism as revealed by x-ray crystallography and NMR. Future Medicinal Chemistry 2:9, pages 1451-1468.
Crossref
Crossref
A L Zackrisson, B Lindblom & J Ahlner. (2009) High Frequency of Occurrence of CYP2D6 Gene Duplication/Multiduplication Indicating Ultrarapid Metabolism Among Suicide Cases. Clinical Pharmacology & Therapeutics 88:3, pages 354-359.
Crossref
Crossref
Hong-Wu Shen, Chao Wu, Xi-Ling Jiang & Ai-Ming Yu. (2010) Effects of monoamine oxidase inhibitor and cytochrome P450 2D6 status on 5-methoxy-N,N-dimethyltryptamine metabolism and pharmacokinetics. Biochemical Pharmacology 80:1, pages 122-128.
Crossref
Crossref
Natasha T. Snider, Vyvyca J. Walker & Paul F. Hollenberg. (2010) Oxidation of the Endogenous Cannabinoid Arachidonoyl Ethanolamide by the Cytochrome P450 Monooxygenases: Physiological and Pharmacological Implications. Pharmacological Reviews 62:1, pages 136-154.
Crossref
Crossref
Silvio Caccia, Silvio Garattini, Luca Pasina & Alessandro Nobili. (2009) Predicting the Clinical Relevance of Drug Interactions From Pre-Approval Studies. Drug Safety 32:11, pages 1017-1039.
Crossref
Crossref
Chao Wu, Xi-Ling Jiang, Hong-Wu Shen & Ai-Ming Yu. (2009) Effects of CYP2D6 status on harmaline metabolism, pharmacokinetics and pharmacodynamics, and a pharmacogenetics-based pharmacokinetic model. Biochemical Pharmacology 78:6, pages 617-624.
Crossref
Crossref
Eva M Peñas-LLedó, Pedro Dorado, Rodrigo Pacheco, Idilio González & Adrián LLerena. (2009)
Relation between
CYP2D6
genotype, personality, neurocognition and overall psychopathology in healthy volunteers
. Pharmacogenomics 10:7, pages 1111-1120.
Crossref
Crossref
Fabien Dutheil, Sandrine Dauchy, Monique Diry, Véronique Sazdovitch, Olivier Cloarec, Lucille Mellottée, Ivan Bièche, Magnus Ingelman-Sundberg, Jean-Pierre Flinois, Isabelle de Waziers, Philippe Beaune, Xavier Declèves, Charles Duyckaerts & Marie-Anne Loriot. (2009) Xenobiotic-Metabolizing Enzymes and Transporters in the Normal Human Brain: Regional and Cellular Mapping as a Basis for Putative Roles in Cerebral Function. Drug Metabolism and Disposition 37:7, pages 1528-1538.
Crossref
Crossref
Hong-Wu ShenXi-Ling JiangAi-Ming Yu. (2009)
Development of a LC–MS/MS method to analyze 5-methoxy-
N
,
N
-dimethyltryptamine and bufotenine: application to pharmacokinetic study
. Bioanalysis 1:1, pages 87-95.
Crossref
Crossref
Monique J BijlHendrika J Luijendijk, Julia F van den BergLoes E VisserRon HN van SchaikAlbert HofmanArnold G VultoTeun van GelderHenning TiemeierBruno HCh Stricker. (2009)
Association between the
CYP2D6*4
polymorphism and depression or anxiety in the elderly
. Pharmacogenomics 10:4, pages 541-547.
Crossref
Crossref
Xi-Ling Jiang, Hong-Wu Shen & Ai-Ming Yu. (2009) Pinoline May be Used as a Probe for CYP2D6 Activity. Drug Metabolism and Disposition 37:3, pages 443-446.
Crossref
Crossref
Katsutoshi Yoshizato & Chise Tateno. (2009) A Human Hepatocyte-Bearing Mouse: An Animal Model to Predict Drug Metabolism and Effectiveness in Humans. PPAR Research 2009, pages 1-11.
Crossref
Crossref
Wei-Yan Zhang, You-Bin Tu, Robert L. Haining & Ai-Ming Yu. (2009) Expression and Functional Analysis of CYP2D6.24, CYP2D6.26, CYP2D6.27, and CYP2D7 Isozymes. Drug Metabolism and Disposition 37:1, pages 1-4.
Crossref
Crossref
Hiroshi Suemizu, Masami Hasegawa, Kenji Kawai, Kenji Taniguchi, Makoto Monnai, Masatoshi Wakui, Makoto Suematsu, Mamoru Ito, Gary Peltz & Masato Nakamura. (2008) Establishment of a humanized model of liver using NOD/Shi-scid IL2Rgnull mice. Biochemical and Biophysical Research Communications 377:1, pages 248-252.
Crossref
Crossref
Natasha T. Snider, Matthew J. Sikora, Chitra Sridar, Thomas J. Feuerstein, James M. Rae & Paul F. Hollenberg. (2008) The Endocannabinoid Anandamide Is a Substrate for the Human Polymorphic Cytochrome P450 2D6. Journal of Pharmacology and Experimental Therapeutics 327:2, pages 538-545.
Crossref
Crossref
Idilio GonzálezEva M Peñas-LledóBárbaro Pérez, Pedro Dorado, Mayra ÁlvarezAdrián LLerena. (2008) Relation between CYP2D6 phenotype and genotype and personality in healthy volunteers. Pharmacogenomics 9:7, pages 833-840.
Crossref
Crossref
J. Andrew Williams, Tommy Andersson, Tommy B. Andersson, Rebecca Blanchard, Martin Otto Behm, Nadine Cohen, Timi Edeki, Monique Franc, Kathleen M. Hillgren, Keith J. Johnson, David A. Katz, Mark N. Milton, Bernard P. Murray, Joseph W. Polli, Deb Ricci, Lisa A. Shipley, Subrahmanyam Vangala & Steven A. Wrighton. (2008) PhRMA White Paper on ADME Pharmacogenomics. The Journal of Clinical Pharmacology 48:7, pages 849-889.
Crossref
Crossref
Ai-Ming Yu. (2008) Indolealkylamines: Biotransformations and Potential Drug–Drug Interactions. The AAPS Journal 10:2.
Crossref
Crossref
Melanie A. Felmlee, Hoi-Kei Lon, Frank J. Gonzalez & Ai-Ming Yu. (2008) Cytochrome P450 Expression and Regulation in CYP3A4/CYP2D6 Double Transgenic Humanized Mice. Drug Metabolism and Disposition 36:2, pages 435-441.
Crossref
Crossref
Pedro Dorado, Eva M Pe as-LLed & Adri n LLerena. (2007)
CYP2D6
polymorphism: implications for antipsychotic drug response, schizophrenia and personality traits
. Pharmacogenomics 8:11, pages 1597-1608.
Crossref
Crossref
Eleni Aklillu, Werner Kalow, Laszlo Endrenyi, Patricia Harper, Jun Miura & Vural Ozdemir. (2007) CYP2D6 and DRD2 genes differentially impact pharmacodynamic sensitivity and time course of prolactin response to perphenazine. Pharmacogenetics and Genomics 17:11, pages 989-993.
Crossref
Crossref
Hong Wu, Weijiang Yu, Lijun Huang, Jing Wang, Xiaobo Tang, Wei Yang, Yan Liu, Huiyan Yu & Daling Zhu. (2007) Effect of sodium ozagrel on the activity of rat CYP2D6. European Journal of Pharmacology 573:1-3, pages 55-59.
Crossref
Crossref
Vural Ozdemir, Leif Bertilsson, Jun Miura, Erin Carpenter, Christopher Reist, Patricia Harper, Jolanta Widén, Jan-Olof Svensson, Lawrence J. Albers, James L. Kennedy, Laszlo Endrenyi & Werner Kalow. (2007) CYP2D6 genotype in relation to perphenazine concentration and pituitary pharmacodynamic tissue sensitivity in Asians: CYP2D6–serotonin–dopamine crosstalk revisited. Pharmacogenetics and Genomics 17:5, pages 339-347.
Crossref
Crossref
B. Oesch-Bartlomowicz & F. Oesch. 2007. Comprehensive Medicinal Chemistry II. Comprehensive Medicinal Chemistry II
193
214
.
Vural OzdemirArzu GunesMarja-Liisa DahlM Gabriella ScordoBryn Williams-JonesToshiyuki Someya. (2006) Could endogenous substrates of drug-metabolizing enzymes influence constitutive physiology and drug target responsiveness?. Pharmacogenomics 7:8, pages 1199-1210.
Crossref
Crossref
Yueying Zhen, Ondřej Slanař, Kristopher W. Krausz, Chi Chen, Josef Slavík, Kerry L. McPhail, T. Mark Zabriskie, František Perlík, Frank J. Gonzalez & Jeffrey R. Idle. (2006) 3,4-Dehydrodebrisoquine, a Novel Debrisoquine Metabolite Formed from 4-Hydroxydebrisoquine That Affects the CYP2D6 Metabolic Ratio. Drug Metabolism and Disposition 34:9, pages 1563-1574.
Crossref
Crossref
Frank J. GonzalezAi-Ming Yu. (2006) CYTOCHROME P450 AND XENOBIOTIC RECEPTOR HUMANIZED MICE. Annual Review of Pharmacology and Toxicology 46:1, pages 41-64.
Crossref
Crossref
Sharon L. Miksys, Connie Cheung, Frank J. Gonzalez & Rachel F. Tyndale. (2005) HUMAN CYP2D6 AND MOUSE CYP2DS: ORGAN DISTRIBUTION IN A HUMANIZED MOUSE MODEL. Drug Metabolism and Disposition 33:10, pages 1495-1502.
Crossref
Crossref
Julia Kirchheiner, Hanns-Benjamin Henckel, Leonora Franke, Ingolf Meineke, Mladen Tzvetkov, Ralf Uebelhack, Ivar Roots & Jürgen Brockmöller. (2005) Impact of the CYP2D6 ultra-rapid metabolizer genotype on doxepin pharmacokinetics and serotonin in platelets. Pharmacogenetics and Genomics 15:8, pages 579-587.
Crossref
Crossref
Ai-Ming Yu, Katsumi Fukamachi, Kristopher W. Krausz, Connie Cheung & Frank J. Gonzalez. (2005) Potential Role for Human Cytochrome P450 3A4 in Estradiol Homeostasis. Endocrinology 146:7, pages 2911-2919.
Crossref
Crossref